371 related articles for article (PubMed ID: 18506083)
1. Impact of increased PPARgamma activity in adipocytes in vivo on adiposity, insulin sensitivity and the effects of rosiglitazone treatment.
Takasawa K; Kubota N; Terauchi Y; Kadowaki T
Endocr J; 2008 Aug; 55(4):767-76. PubMed ID: 18506083
[TBL] [Abstract][Full Text] [Related]
2. Adipocytes fail to maintain cellular identity during obesity due to reduced PPARγ activity and elevated TGFβ-SMAD signaling.
Roh HC; Kumari M; Taleb S; Tenen D; Jacobs C; Lyubetskaya A; Tsai LT; Rosen ED
Mol Metab; 2020 Dec; 42():101086. PubMed ID: 32992037
[TBL] [Abstract][Full Text] [Related]
3. PPARgamma regulates adipose triglyceride lipase in adipocytes in vitro and in vivo.
Kershaw EE; Schupp M; Guan HP; Gardner NP; Lazar MA; Flier JS
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1736-45. PubMed ID: 17848638
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor (PPAR)alpha activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARalpha, PPARgamma, and their combination.
Tsuchida A; Yamauchi T; Takekawa S; Hada Y; Ito Y; Maki T; Kadowaki T
Diabetes; 2005 Dec; 54(12):3358-70. PubMed ID: 16306350
[TBL] [Abstract][Full Text] [Related]
5. Brain PPAR-γ promotes obesity and is required for the insulin-sensitizing effect of thiazolidinediones.
Lu M; Sarruf DA; Talukdar S; Sharma S; Li P; Bandyopadhyay G; Nalbandian S; Fan W; Gayen JR; Mahata SK; Webster NJ; Schwartz MW; Olefsky JM
Nat Med; 2011 May; 17(5):618-22. PubMed ID: 21532596
[TBL] [Abstract][Full Text] [Related]
6. A selective peroxisome proliferator-activated receptor gamma modulator with distinct fat cell regulation properties.
Fujimura T; Kimura C; Oe T; Takata Y; Sakuma H; Aramori I; Mutoh S
J Pharmacol Exp Ther; 2006 Aug; 318(2):863-71. PubMed ID: 16682454
[TBL] [Abstract][Full Text] [Related]
7. Cystathionine γ lyase-hydrogen sulfide increases peroxisome proliferator-activated receptor γ activity by sulfhydration at C139 site thereby promoting glucose uptake and lipid storage in adipocytes.
Cai J; Shi X; Wang H; Fan J; Feng Y; Lin X; Yang J; Cui Q; Tang C; Xu G; Geng B
Biochim Biophys Acta; 2016 May; 1861(5):419-29. PubMed ID: 26946260
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome Proliferator-Activated Receptor γ and Its Role in Adipocyte Homeostasis and Thiazolidinedione-Mediated Insulin Sensitization.
Wang QA; Zhang F; Jiang L; Ye R; An Y; Shao M; Tao C; Gupta RK; Scherer PE
Mol Cell Biol; 2018 May; 38(10):. PubMed ID: 29483301
[TBL] [Abstract][Full Text] [Related]
9. Antagonism of peroxisome proliferator-activated receptor gamma prevents high-fat diet-induced obesity in vivo.
Nakano R; Kurosaki E; Yoshida S; Yokono M; Shimaya A; Maruyama T; Shibasaki M
Biochem Pharmacol; 2006 Jun; 72(1):42-52. PubMed ID: 16696951
[TBL] [Abstract][Full Text] [Related]
10. CMHX008, a novel peroxisome proliferator-activated receptor γ partial agonist, enhances insulin sensitivity in vitro and in vivo.
Ming Y; Hu X; Song Y; Liu Z; Li J; Gao R; Zhang Y; Mei H; Guo T; Xiao L; Wang B; Wu C; Xiao X
PLoS One; 2014; 9(7):e102102. PubMed ID: 25004107
[TBL] [Abstract][Full Text] [Related]
11. Obese mice lacking inducible nitric oxide synthase are sensitized to the metabolic actions of peroxisome proliferator-activated receptor-gamma agonism.
Dallaire P; Bellmann K; Laplante M; Gélinas S; Centeno-Baez C; Penfornis P; Peyot ML; Latour MG; Lamontagne J; Trujillo ME; Scherer PE; Prentki M; Deshaies Y; Marette A
Diabetes; 2008 Aug; 57(8):1999-2011. PubMed ID: 18458147
[TBL] [Abstract][Full Text] [Related]
12. The potential insulin sensitizing and glucose lowering effects of a novel indole derivative in vitro and in vivo.
Li YY; Wu HS; Tang L; Feng CR; Yu JH; Li Y; Yang YS; Yang B; He QJ
Pharmacol Res; 2007 Oct; 56(4):335-43. PubMed ID: 17889553
[TBL] [Abstract][Full Text] [Related]
13. A Novel Peroxisome Proliferator-activated Receptor (PPAR)α Agonist and PPARγ Antagonist, Z-551, Ameliorates High-fat Diet-induced Obesity and Metabolic Disorders in Mice.
Shiomi Y; Yamauchi T; Iwabu M; Okada-Iwabu M; Nakayama R; Orikawa Y; Yoshioka Y; Tanaka K; Ueki K; Kadowaki T
J Biol Chem; 2015 Jun; 290(23):14567-81. PubMed ID: 25907553
[TBL] [Abstract][Full Text] [Related]
14. FKBP51 Null Mice Are Resistant to Diet-Induced Obesity and the PPARγ Agonist Rosiglitazone.
Stechschulte LA; Qiu B; Warrier M; Hinds TD; Zhang M; Gu H; Xu Y; Khuder SS; Russo L; Najjar SM; Lecka-Czernik B; Yong W; Sanchez ER
Endocrinology; 2016 Oct; 157(10):3888-3900. PubMed ID: 27442117
[TBL] [Abstract][Full Text] [Related]
15. PPAR agonist-induced reduction of Mcp1 in atherosclerotic plaques of obese, insulin-resistant mice depends on adiponectin-induced Irak3 expression.
Hulsmans M; Geeraert B; Arnould T; Tsatsanis C; Holvoet P
PLoS One; 2013; 8(4):e62253. PubMed ID: 23620818
[TBL] [Abstract][Full Text] [Related]
16. Nuclear receptors as targets for drug development: molecular mechanisms for regulation of obesity and insulin resistance by peroxisome proliferator-activated receptor gamma, CREB-binding protein, and adiponectin.
Tsuchida A; Yamauchi T; Kadowaki T
J Pharmacol Sci; 2005 Feb; 97(2):164-70. PubMed ID: 15725703
[TBL] [Abstract][Full Text] [Related]
17. Disruption of inducible 6-phosphofructo-2-kinase impairs the suppressive effect of PPARγ activation on diet-induced intestine inflammatory response.
Guo X; Li H; Xu H; Halim V; Thomas LN; Woo SL; Huo Y; Chen YE; Sturino JM; Wu C
J Nutr Biochem; 2013 May; 24(5):770-5. PubMed ID: 22841546
[TBL] [Abstract][Full Text] [Related]
18. HSPA12A is required for adipocyte differentiation and diet-induced obesity through a positive feedback regulation with PPARγ.
Zhang X; Chen X; Qi T; Kong Q; Cheng H; Cao X; Li Y; Li C; Liu L; Ding Z
Cell Death Differ; 2019 Nov; 26(11):2253-2267. PubMed ID: 30742088
[TBL] [Abstract][Full Text] [Related]
19. Rosiglitazone increases indexes of stearoyl-CoA desaturase activity in humans: link to insulin sensitization and the role of dominant-negative mutation in peroxisome proliferator-activated receptor-gamma.
Risérus U; Tan GD; Fielding BA; Neville MJ; Currie J; Savage DB; Chatterjee VK; Frayn KN; O'Rahilly S; Karpe F
Diabetes; 2005 May; 54(5):1379-84. PubMed ID: 15855323
[TBL] [Abstract][Full Text] [Related]
20. Pioglitazone reduces islet triglyceride content and restores impaired glucose-stimulated insulin secretion in heterozygous peroxisome proliferator-activated receptor-gamma-deficient mice on a high-fat diet.
Matsui J; Terauchi Y; Kubota N; Takamoto I; Eto K; Yamashita T; Komeda K; Yamauchi T; Kamon J; Kita S; Noda M; Kadowaki T
Diabetes; 2004 Nov; 53(11):2844-54. PubMed ID: 15504964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
